Shalby Ltd.
| BSE: 540797 | Sector: Health care |
| NSE: SHALBY | ISIN Code: INE597J01018 |
| BSE 11:04 | 17 May | 108.80 |
3.65 (3.47%) |
OPEN
107.75 |
HIGH
112.00 |
LOW
107.65 |
| NSE 10:49 | 17 May | 108.55 |
3.15 (2.99%) |
OPEN
105.75 |
HIGH
113.55 |
LOW
105.75 |
| OPEN | 107.75 |
| PREVIOUS CLOSE | 105.15 |
| VOLUME | 1880 |
| 52-Week high | 214.00 |
| 52-Week low | 103.65 |
| P/E | 17.16 |
| Mkt Cap.(Rs cr) | 1,175 |
| Buy Price | 108.50 |
| Buy Qty | 951.00 |
| Sell Price | 109.05 |
| Sell Qty | 41.00 |
Shalby Ltd. (SHALBY) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 542.40 | -8.35 | -1.52 | 3112.91 |
| Cipla | 923.10 | -10.00 | -1.07 | 2468.28 |
| Dr Reddy's Labs | 3899.60 | 12.35 | 0.32 | 2186.40 |
| Sun Pharma.Inds. | 886.45 | 0.70 | 0.08 | 2139.70 |
| Divi's Lab. | 4238.75 | 19.20 | 0.46 | 1954.72 |
| Alkem Lab | 2901.15 | -0.75 | -0.03 | 1685.08 |
| Glenmark Pharma. | 392.55 | 0.05 | 0.01 | 1649.45 |
| Zydus Lifesci. | 344.95 | -0.20 | -0.06 | 1476.20 |
| Lupin | 681.85 | -2.80 | -0.41 | 1258.62 |
| Alembic Pharma | 737.30 | -2.60 | -0.35 | 1175.39 |
| Ipca Labs. | 984.15 | 0.25 | 0.03 | 1140.77 |
| Torrent Pharma. | 2572.50 | -11.95 | -0.46 | 1137.85 |
| Gland Pharma | 3140.05 | 30.40 | 0.98 | 997.01 |
| Laurus Labs | 550.80 | 8.50 | 1.57 | 956.11 |
| Sanofi India | 6605.80 | -1.30 | -0.02 | 944.40 |
| Abbott India | 16758.60 | 229.40 | 1.39 | 690.69 |
| Ajanta Pharma | 1672.40 | -11.20 | -0.67 | 675.64 |
| Wockhardt | 244.10 | 5.30 | 2.22 | 593.29 |
| Granules India | 241.60 | -0.55 | -0.23 | 552.78 |
| Pfizer | 4252.00 | 44.25 | 1.05 | 497.61 |
Quick Links for Shalby:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
